ArticleReproductive sciences (Thousand Oaks, Calif.)2025

Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model.

Michael F Neblett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.